Price-file publication check · 45 CFR § 180
C · 70
This hospital's published file contains part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
15,088
Insurances with rates
16
CPT / HCPCS codes
11,703
Most expensive procedures (gross)
J0225
$246,602
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J0225
$246,602
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J1303
$132,318
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
J1303
$132,318
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
90378
$97,068
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
90378
$97,068
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
J0285
$96,072
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
J0285
$96,072
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
C1877
$82,285
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1877
$82,285
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1882
$62,058
ACTICOR 7 HF-T 429523
Gross
$187,374
C1882
$62,058
ACTICOR 7 HF-T 429523
Gross
$187,374
J2020
$58,591
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
J2020
$58,591
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
C1605
$56,424
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1605
$56,424
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1824
$54,073
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
C1824
$54,073
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
J1747
$53,883
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
J1747
$53,883
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
C1820
$51,722
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1820
$51,722
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1826
$51,722
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
C1826
$51,722
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
J9266
$51,550
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
J9266
$51,550
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
C1767
$50,652
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C1767
$50,652
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C2624
$49,371
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
C2624
$49,371
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
J9228
$48,677
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9228
$48,677
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9359
$48,556
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J9359
$48,556
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J0222
$46,717
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
J0222
$46,717
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
C2616
$41,730
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
C2616
$41,730
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
J9229
$41,084
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
J9229
$41,084
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
C1787
$38,321
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
C1787
$38,321
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
77371
$37,967
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
77371
$37,967
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
J9350
$37,945
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
J9350
$37,945
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
C1822
$37,616
IPG W/KIT NIPG1500
Gross
$113,576
C1822
$37,616
IPG W/KIT NIPG1500
Gross
$113,576
L8614
$36,814
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
L8614
$36,814
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $246,602 | $409,518 | $558,434 | 4 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $246,602 | $372,289 | $558,434 | 3 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $132,318 | $219,733 | $299,636 | 4 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $132,318 | $221 | $299,636 | 29 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $97,068 | $161,196 | $219,812 | 4 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $97,068 | $340 | $219,812 | 30 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $96,072 | $159,541 | $217,556 | 4 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $96,072 | $145,037 | $217,556 | 3 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $82,285 | $136,646 | $186,336 | 3 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $82,285 | $124,224 | $186,336 | 3 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $62,058 | $131,162 | $140,531 | 3 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $62,058 | $93,687 | $140,531 | 3 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $58,591 | $97,298 | $132,679 | 4 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $58,591 | $146 | $132,679 | 4 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $56,424 | $119,255 | $127,773 | 3 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $56,424 | $85,182 | $127,773 | 3 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $54,073 | $89,796 | $122,449 | 3 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $54,073 | $81,633 | $122,449 | 3 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $53,883 | $89,480 | $122,018 | 4 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $53,883 | $81,345 | $122,018 | 3 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $51,722 | $85,892 | $117,125 | 3 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $51,722 | $78,084 | $117,125 | 3 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $51,722 | $85,892 | $117,125 | 3 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $51,722 | $78,084 | $117,125 | 3 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $51,550 | $85,606 | $116,735 | 4 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $51,550 | $11,049 | $135,004 | 30 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $50,652 | $84,115 | $114,703 | 3 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $50,652 | $76,469 | $114,703 | 3 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $49,371 | $81,988 | $111,801 | 3 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $49,371 | $74,534 | $111,801 | 3 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $48,677 | $80,835 | $110,230 | 4 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $48,677 | $172 | $110,230 | 30 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $48,556 | $80,633 | $109,955 | 4 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $48,556 | $73,303 | $109,955 | 3 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $46,717 | $77,580 | $105,791 | 4 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $46,717 | $98.83 | $105,791 | 29 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $41,730 | $69,299 | $94,499 | 3 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $41,730 | $19,818 | $94,499 | 30 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $41,084 | $68,225 | $93,035 | 4 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $41,084 | $2,580 | $93,035 | 29 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $38,321 | $63,638 | $86,779 | 3 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $38,321 | $57,853 | $86,779 | 3 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $37,967 | $82,538 | $85,977 | 2 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $37,967 | $8,665 | $85,977 | 30 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $37,945 | $63,014 | $85,928 | 4 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $37,945 | $57,285 | $85,928 | 3 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $37,616 | $62,467 | $85,182 | 3 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $37,616 | $56,788 | $85,182 | 3 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $36,814 | $61,135 | $83,365 | 3 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $36,814 | $55,577 | $83,365 | 3 |
Showing top 50 of 15,088 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.